Popular listings

June 1st 2007 marked a new era for the German property sector as it joined the likes of the USA, Canada, Australia, Japan, Hong Kong, Singapore, France, Netherlands and the UK as an official REIT jurisdiction. Part of a global series of real estate events, REIT World is regarded as THE forum for getting up to speed with market developments. It is the ONLY established and trusted event 100% focused on debating the capital market angle behind real estate. . What will you gain from attending? REIT World Germany is an incredible opportunity to get up to speed with the whole real estate and capital markets debate within 2 short days. And attending will provide you with: • An invaluable insight into how leading companies have been impacted by converting to REIT status • Practical tips and guidance on which financial structuring strategy could work for you • Our experts showing you how REITs have transformed the global real estate market, and how they could impact on Germany • Information on how leading institutional investors are re-aligning their asset allocation strategies to take advantage of the real estate opportunities • Speed networking; this is THE ONLY REAL ESTATE conference where you get an opportunity to meet with nearly every delegate in a single ONE hour session REIT World is the original real estate forum of choice for leading property companies, REITs, institutional investors, and advisors. With a focus on bringing the executives at the deep end of the market to your attention this is your opportunity to hear more from investors and property companies than from sales people. Hear from THE best speakers in the industry • Alexander Rychter, Managing Director, BFW Bund • Stephan Huessen, Executive Partner, FOM Real Estate GmbH • Dr Oscar Kienzle, CEO, IC Immobilien • Christoph Hommerich, Head of Property Business, Fraport • Herman Aukamp, CIO Real Estate, Nordrheinische Aerzteversorgung • Barbara Deisenrieder, Managing Director, AMB Generali Immobilien • Daniel Piazolo, Managing Director, IPD Germany • Thomas Schwartz, Managing Director, VCM Capital Management • Joe Houlihan, CEO European Real Estate, Cohen & Steers • Jeremy Stewardson, CEO, Eagle Asset Management • Michael A. Kremer, Managing Director, Strategic Value Partners (Deutschland) • Sabine Offermann, Partner, Opti M&A • Dr Rainer Zitelmann, Managing Director, Dr ZitelmannPB. GMBH This forum is a MUST for anyone involved in the real estate sector. If you want to learn how to maximise the returns and effectiveness of your real estate portfolio then you need to register asap. It will be your most cost and time -effective solution for making the right decision. Conact Please visit the website: http://www.terrapinn.com/2007/reiteu/

The rules of the takeover game have been changed by recent adjustments in financial markets and the significant involvement of private equity players and hedge funds in M&A deals. With M&A still dominating headlines, attend this event to get up to speed on new strategies so your deal team will be prepared to take advantage of consolidation opportunities. What sets this conference apart from others is the quality of speakers and practical nature of the presentations from key industry participants. An impressive faculty of senior industry executives, investment bankers and professionals will focus on a variety of case studies from recent high profile transactions as they address, among other things: • Investment bankers’ perspectives on global, cross-border and domestic deals – where is the market headed in 2008? • What are some of the leading M&A strategies in mining and income funds? • How will the end of a debt-driven bull market affect M&A valuations? • What do private equity players and hedge funds look for in M&A transactions both as an investor, buyer and seller? • How do you build a Company for sale and execute an auction? • What impact does the increasingly complex corporate governance environment have on your transaction? • How to avoid legal minefields and serious execution risks in Going Private transactions • Successful use of the “just say no” defence in a hostile takeover • How to assess and manage business and legal risks associated with litigious deals • Structuring cross-border and domestic deals to comply with recent tax, antitrust (regulatory) and legal developments • Latest technology and structures evolving around the privatization of an income fund At this Advanced Mergers & Acquisitions conference, the in-depth nature of the topics will provide attendees with the practical information necessary in order to compete in rapidly evolving M&A markets. We believe that you will come away from this conference with a better understanding of the key drivers in M&A across a wide variety of industry sectors. Our speakers have been key participants in deals involving in excess of $50 billion, in aggregate, over the past twelve months and can speak first hand about the cutting edge issues. Please join us for this conference - it will be an excellent investment of your time.

Understand the regulatory framework governing the financial services industry. -Know essential regulations that have to be complied with. -Introduction to Basel II. Seminar Facilitators: Mr. Adam K.K. Wong, B.Acc, FCPA, Certified Professional Trainer Dr. Jeffery C.K. Lim, Ph.D., C.Sci., C.Maths., FIMA, FRM, PRM

Event Profile: Middle East Natural & Organic Products Expo will include a new profile, to enhance the show. Here, the entire spectrum of natural & organic products up to packaging in an environment-friendly method will make the exhibition truly a haven for all things natural and organic. Highlights: With increased marketing focus in previous year the show attracted 3896 trade and professional visitors and about 2672 consumers, inciting over 75% of the exhibitors to repeat their participation for the 2006 edition of the event. Visitor's Profile: Importers/Exporters/Distributors/Wholesalers/Trading houses/Business Groups/ Collaboration & joint venture seekers/Manufacturers/Producers/Overseas buyers / Agents / Consultants / Franchisees are the target visitors. Exhibitor's Profile: Profile for exhibit include Natural Remedies, Pharma, Health, Nutritional Products/Dietary Supplements, Beauty & Personal Care Products, Food & Beverage, Herbs & Spices, Relaxation Products, Fabrics & Accessories, Gifts & Novelties, Furniture etc.

Data Governance has emerged as a new discipline in response to both regulatory requirements as well as business necessity. Following two successful Data Governance Conferences in the USA, IRM UK is pleased to partner with Wilshire Conferences and DebTech International for the Data Governance Europe Conference that will be held in the UK in February 2008. This conference will focus on the “how to's” in getting started, deploying and sustaining a data governance and stewardship programme. Highlights include: Learn how to Design, Implement and Sustain a top-notch Data Governance Initiative in your Organisation Choose from 5 pre-conference tutorials and 3 conference tracks Topics include: Data Governance basics How to get started in data governance Real life success stories Data Stewardship MDM and governance Privacy Data protection Best practices in data governance Tips on improving communications in data governance Business intelligence and data governance Data governance frameworks, maturity models and methodologies How to deal with change, cultural and political issues Data governance roles and responsibilities Pitfalls to avoid in data governance initiatives

Target audience: cardiolgoists, internists, family physicians, endocrinologists, physician assistants, nurse practitioners, nurses, pharmacists, dietitians, psychologists

SPECIFIC OBJECTIVES - DAY 1 - DELIRIUM IN THE ELDERLY – CURRENT CONCEPTS – Diagnostic features and common causes of delirium. Distinguish between delirium and dementia. Causes of persistent delirium. Non-pharmacologic and pharmacologic treatment approaches to the delirious patient. EXERCISE PROGRAM IN THE ELDERLY – Relationship between maximal oxygen consumption, aging, and functional status. Potential benefits of exercise. Risks of exercise and how to minimize them. Components of an exercise program. DEMENTIA IN THE ELDERLY – Prevalence and significance of dementia. Common causes of dementia and the value of objectifying cognitive performance. Atypical patterns and differential diagnosis of dementia syndromes. Risks and benefits of commonly used drugs to treat dementia. Medical evaluation of a newly identified patient. OFFICE ORTHOPEDICS IN THE OLDER PATIENT – Common causes of acute low back pain. Symptoms and treatment of spinal stenosis. Causes of shoulder pain. Common causes of neck pain. DAY 2 - ADVANCED NUTRITIONAL ASSESSMENT AND THERAPY – Metabolic changes and inflammatory effects of aging and poor diet. Utilize readily available clinical data to make accurate and comprehensive nutritional assessments. Therapeutic nutritional approaches for acutely ill, chronically ill, and frail patients. Apply nutritional therapies towards improved wellness. TREATMENT OF CHRONIC PAIN IN THE ELDERLY – Alterations in body composition and physiology that alter the pharmacology of various analgesics. Adverse effects of NSAIDs. Use of the opioids and adjunctive medications in the treatment of chronic pain. Non-pharmacological treatments available for the treatment of chronic pain. VITAMIN B-12 DEFICIENCY IN THE ELDERLY – Normal physiology and the pathophysiology of B-12 deficiency and its causes. Use of metabolic markers in B-12 deficiency. Work-up of B-12 deficiency in clinical practice. OSTEOARTHRITIS: DIAGNOSIS AND TREATMENT IN THE OLDER PATIENT – Describe newer understandings of the pathophysiology of OA. Recognize the typical and atypical clinical features of OA. Describe the various treatments of OA and how to integrate them. Distinguish OA symptoms from those of other localized or generalized disorders. DAY 3 - OSTEOPOROSIS: CONTEMPORARY DIAGNOSIS AND TREATMENT – Define osteoporosis pathologically and by the WHO standards. Distinguish between the effects on bone metabolism of aging and those during the post-menopausal period. Usefulness of the T-score on DEXA scan reports and how to incorporate bone markers into treatment decision. Anti-resorptive agents available for the treatment of osteoporosis. SENSIBLE APPROACHES TO GERIATRIC INFECTIONS – Atypical presentation of infectious illness. Causes of pneumonia and UTI and describe the approach to antibiotic selection. Considerations in emerging antibiotic resistance. Issues in reasonable antibiotic use. RHEUMATOLOGIC LAB TESTS AND RHEUMATOID ARTHRITIS IN THE ELDERLY – Impact of aging on the sensitivity and specificity of rheumatologic lab tests. Alterations in the presentation of rheumatoid arthritis. Use of corticosteroids in elderly onset rheumatoid arthritis. Complications of methotrexate therapy and proper lab monitoring during its use. Role of newer treatments for rheumatoid arthritis. SENSIBLE PRESCRIBING PRACTICES FOR THE ELDERLY – The limits of studies on drug safety and efficacy. Subtle but significant drug side effects. Undesirable prescribing practices and better approaches. DAY 4 - GERIATRIC DEPRESSION: ADVANCES IN DIAGNOSIS AND TREATMENT – Clinical presentations of depressive syndromes. Utility and application of the Geriatric Depression Scale. Relative advantages and disadvantages of the various medications available for treatment of depression. Benefits of non-pharmacologic treatments alone or in conjunction with medical treatments. MUSCULOSKELETAL EXAM AND ARTICULAR AND SOFT TISSUE INJECTIONS FOR THE PRIMARY CARE PHYSICIAN – Equipment necessary for specific injections. Contraindications to and complications of injections. Proper technique for handling of and the necessary tests on synovial fluid. The technique for the injection of several commonly affected structures. CONTEMPORARY ISSUES IN END OF LIFE CARE – Aapproach to assessment of the whole patient in a hospice setting. Practical and effective approaches to common physical symptoms in the terminally ill. Effective clinical care of patients in the last days of life. Dementia as a terminal illness. DAY 5 - POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS – Typical symptoms, physical findings, and laboratory abnormalities in polymyalgia rheumatica. Treatment options for PMR. Typical and atypical presentations of GCA. Appropriate indication and technique for temporal artery biopsy. Most effective treatment and the most serious complications of GCA. RISK MANAGEMENT AND CARE OF THE ELDERLY – Principles of effective risk management practices. Newer concepts and approaches in dealing with medical errors. Benefits of honest disclosure of medical errors. GOUT AND PSEUDOGOUT IN THE ELDERLY – The unique characteristics of gout. Factors that impact the presentation and treatment of gout. The Allopurinol hypersensitivity syndrome and predisposing factors. Clinical manifestations of calcium pyrophosphate deposition. Polarized microscopic findings for uric acid and CPPD crystals. IMPROVING COMMUNICATION SKILLS IN MEDICAL PRACTICE – Ways that people perceive communication and process information. Your personal communication strengths and limitations. Communication issues unique to older patients. Practices to maximize effective communication and listening.

As new clinical approaches emerge and technology improves, therapists and educators are increasingly challenged to enhance knowledge of best practices in the treatment and education for clients, patients, and students with AAC and assistive technology needs. How do therapists, educators, and medical professionals assure they are current with new clinical approaches as research and new technology emerges? Join us for the 2008 AAC conference and interact with colleages and nathionally recognized experts in the area of AAC and assistive technology.

An Important Two-Day Comprehensive & Interactive Seminar with Case Studies and Workshops On: - FDA, Today and Tomorrow - FDA Rules and Regulations - FDA’s Initiative on Pharmaceutical cGMPs for the 21st Century - Application and Approval in the US - FDA Inspections - FDA Pre-Approval Inspectional Program Before, During and After - System Based Inspections Quality, Facility & Equipment, Materials, Production, Packaging/Labeling, Lab Controls - A Quality Systems Approach to GMPs - Most Common GMP Deficiencies by Systems - Expectations for cGMPs for Laboratories - Inspections of Combination Devices - Requirements for Inspection Preparations - Surviving an US FDA Audit - Criteria for Warning Letter vs Violation Letter - Responding to FDA FD-483 Distinguished Course Leaders Ms. Maxine Fritz Vice President, Pharmaceutical Quality Systems and Validation Quintiles Consulting Mr. John Godshalk Senior Consultant Biologics Consulting Group Dr. Marla Phillips Senior Compliance Consultant

Main Topics: Pediatrics, child health, biological anthropology, growth and development, body composition, clinical nutrition, community medicine, cytogenetics and biochemical genetics, dermatology and venereal diseases, disability and mental health, endocrinology and diabetes, environmental health impacts, histopathology, laboratory medicine, molecular and immunogenetics, oro-dental diseases, pharmacology and toxicology, prenatal genetics, reproductive health, gynecology and obstetrics, and free papers in medical sciences. Registration fees: US$ 150 which include: opening ceremony, admission to scientific sessions, admission to technical exhibitions, conference kit, certificate of attendance, coffee and lunch breaks. Accommodation: Accommodation can be arranged on request. Payment: Bank trasfere: National Bank of Egypt, Cairo, Account No. 9/450/81761/1. Email: Nrc_med@yahoo.com Contact person: Prof. Dr. Ashraf Shaalan Head of Medical Research Division National Research Centre Cairo, Egypt.